secwatch.observer — SEC 8-K summary
======================================

Issuer:     Liquidia Corp (LQDA)
CIK:        0001819576
Form:       8-K
Filed at:   2025-05-05T23:59:59+00:00
Accession:  0001104659-25-044345
Event type: litigation
Sentiment:  positive
Materiality: 0.80
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Liquidia wins dismissal of UTHR cross-claim over YUTREPIA PH-ILD label; FDA approval path cleared
--------------------------------------------------------------------------------

- District Court dismissed UTHR's cross-claim without prejudice for lack of standing and ripeness.
- FDA can grant final YUTREPIA approval after regulatory exclusivity expires on May 23, 2025.
- PDUFA goal date for YUTREPIA NDA remains May 24, 2025.
- UTHR retains the right to appeal the court's ruling.
- CEO cites court decision as validating FDA's acceptance of PH-ILD indication in NDA.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1819576/000110465925044345/0001104659-25-044345-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1819576/000110465925044345/tm2514002d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-044345

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer